Avalyn Pharma Inc. Common Stock (AVLN) — Financial Flexibility Index
Avalyn Pharma Inc. Common Stock (AVLN) has a Financial Flexibility Index of -0.95x as of June 2026. Free cash flow of $-25.81 Million (operating CF $-26.08 Million minus capex $269.00K) represents -1% of total liabilities ($27.10 Million). Check how tangible is Avalyn Pharma Inc. Common Stock's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avalyn Pharma Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Avalyn Pharma Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see Avalyn Pharma Inc. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Avalyn Pharma Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Avalyn Pharma Inc. Common Stock. Explore Avalyn Pharma Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.21x | $-81.14 Million | $-81.48 Million | $387.54 Million | ▼ -29.7% |
| 2024 | -0.16x | $-48.27 Million | $-48.37 Million | $299.04 Million | — |